Cargando…

Correction: AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models

Detalles Bibliográficos
Autores principales:	Vasireddy, Vidyullatha, Mills, Jason A., Gaddameedi, Rajashekhar, Basner-Tschakarjan, Etiena, Kohnke, Monika, Black, Aaron D., Alexandrov, Krill, Zhou, Shangzhen, Maguire, Albert M., Chung, Daniel C., Mac, Helen, Sullivan, Lisa, Gadue, Paul, Bennicelli, Jeannette L., French, Deborah L., Bennett, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474960/ https://www.ncbi.nlm.nih.gov/pubmed/26090960 http://dx.doi.org/10.1371/journal.pone.0129982

Ejemplares similares

AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models
por: Vasireddy, Vidyullatha, et al.
Publicado: (2013)

Cell-Mediated Immunity to AAV Vectors, Evolving Concepts and Potential Solutions
por: Basner-Tschakarjan, Etiena, et al.
Publicado: (2014)

Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Basner-Tschakarjan, Etiena, et al.
Publicado: (2014)

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)

Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs
por: Haurigot, Virginia, et al.
Publicado: (2010)

Modulation of CD8(+) T cell responses to AAV vectors with IgG-derived MHC class II epitopes
por: Hui, Daniel J, et al.
Publicado: (2013)

Comparative AAV-eGFP Transgene Expression Using Vector Serotypes 1–9, 7m8, and 8b in Human Pluripotent Stem Cells, RPEs, and Human and Rat Cortical Neurons
por: Duong, Thu T., et al.
Publicado: (2019)

An Autogenously Regulated Expression System for Gene Therapeutic Ocular Applications
por: Sochor, Matthew A., et al.
Publicado: (2015)

Author Correction: An Autogenously Regulated Expression System for Gene Therapeutic Ocular Applications
por: Sochor, Matthew A., et al.
Publicado: (2018)

Rab GTPase Prenylation Hierarchy and Its Potential Role in Choroideremia Disease
por: Köhnke, Monika, et al.
Publicado: (2013)

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?
por: Han, Ruofan Connie, et al.
Publicado: (2021)

A Case Study of Choroideremia and Choroideremia Carrier
por: Pidro, Ajla, et al.
Publicado: (2019)

The Biological Activity of AAV Vectors for Choroideremia Gene Therapy Can Be Measured by In Vitro Prenylation of RAB6A
por: Patrício, Maria I., et al.
Publicado: (2018)

Molecular Therapies for Choroideremia
por: Cehajic Kapetanovic, Jasmina, et al.
Publicado: (2019)

Choroideremia Gene Therapy
por: Lam, Byron L., et al.
Publicado: (2021)

Choroideremia: The Endpoint Endgame
por: Abdalla Elsayed, Maram E. A., et al.
Publicado: (2023)

Molecular analysis of the choroideremia gene related clinical findings in two families with choroideremia
por: Lin, Ying, et al.
Publicado: (2011)

Comparing Clinical Perimetry and Population Receptive Field Measures in Patients with Choroideremia
por: Silson, Edward H., et al.
Publicado: (2018)

CRISPR Activation Enhances In Vitro Potency of AAV Vectors Driven by Tissue-Specific Promoters
por: McDougald, Devin S., et al.
Publicado: (2019)

Stem cells set their sights on retinitis pigmentosa
por: Bennicelli, Jeannette L, et al.
Publicado: (2013)

Proof of concept for AAV2/5-mediated gene therapy in iPSC-derived retinal pigment epithelium of a choroideremia patient
por: Cereso, Nicolas, et al.
Publicado: (2014)

Molecular genetic diagnostic techniques in choroideremia
por: Furgoch, Mira J.B., et al.
Publicado: (2014)

Recent advances and future prospects in choroideremia
por: Zinkernagel, Martin S, et al.
Publicado: (2015)

Multimodal Imaging of Photoreceptor Structure in Choroideremia
por: Sun, Lynn W., et al.
Publicado: (2016)

Multimodal imaging in a case of choroideremia
por: Goel, Sugandha, et al.
Publicado: (2019)

Choroideremia associated with an X-autosomal translocation
por: Siu, Victoria M., et al.
Publicado: (1990)

Safety of Same-Eye Subretinal Sequential Readministration of AAV2-hRPE65v2 in Non-human Primates
por: Weed, Lindsey, et al.
Publicado: (2019)

Choroideremia: Update On Clinical Features And Emerging Treatments
por: Brambati, Maria, et al.
Publicado: (2019)

An In Silica Model for RPE Loss Patterns in Choroideremia
por: Young, Benjamin K., et al.
Publicado: (2021)

Clinical and Genetic Findings in Korean Patients with Choroideremia
por: Jo, Woo Gyeong, et al.
Publicado: (2023)

Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo
por: Tolmachova, Tanya, et al.
Publicado: (2013)

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
por: Palejwala, Neal V, et al.
Publicado: (2014)

Next-Generation Sequencing-Based Molecular Diagnosis of Choroideremia
por: Shimizu, Kayo, et al.
Publicado: (2015)

Novel CHM mutations identified in Chinese families with Choroideremia
por: Cai, Xue-Bi, et al.
Publicado: (2016)

Outcome of Full-Thickness Macular Hole Surgery in Choroideremia
por: Talib, Mays, et al.
Publicado: (2017)

Fluorescence Lifetime Imaging Ophthalmoscopy (FLIO) in Patients with Choroideremia
por: Vitale, Alexandra S., et al.
Publicado: (2020)

Choroidal Vascularity Features in Patients with Choroideremia and Cystoid Spaces
por: Iovino, Claudio, et al.
Publicado: (2021)

Structural and Functional Characteristics of Color Vision Changes in Choroideremia
por: Jolly, Jasleen K., et al.
Publicado: (2021)

Choroideremia Carriers: Dark-Adapted Perimetry and Retinal Structures
por: Parmann, Rait, et al.
Publicado: (2022)

Genetic and phenotypic characteristics of three Mainland Chinese families with choroideremia
por: Zhou, Qi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rff9ra1j4a28rjjgua6vsliuqa